Related Experiment Video
Updated: Jun 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications
Isabella Kanzler1, Elisa A Liehn, Rory R Koenen
1Institute for Molecular Cardiovascular Research,Interdisciplinary Center for Clinical Research Aachen, RWTH Aachen University, Germany.
Insights
Chemokines play a key role in cardiovascular diseases like atherosclerosis and heart attack. Targeting chemokine pathways offers promising therapeutic strategies for these major causes of death.
Area of Science:
- Cardiovascular Science
- Immunology
- Pharmacology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of mortality in Western countries.
- Chemokines are critical regulators of leukocyte migration and function, influencing CVD initiation and progression.
- Current research focuses on targeting chemokine pathways for therapeutic interventions.
Purpose of the Study:
- To review the role of chemokines in cardiovascular diseases.
- To evaluate the therapeutic potential of modulating chemokine pathways.
- To highlight considerations for future drug development targeting chemokines in CVDs.
Main Methods:
- Review of existing studies on chemokine antagonism and receptor blockade in cardiovascular pathology.
- Analysis of specific chemokine pathways (CCL2/CCR2, CCL5/CCR1-CCR5, CXCL12/CXCR4).
- Consideration of various modulation strategies: receptor-ligand interaction, chemokine-glycosaminoglycan interaction, heteromerization, and signaling interference.
Main Results:
- Modulating chemokine pathways shows significant potential for cardiovascular drug development.
- Targeting specific chemokine-receptor interactions offers therapeutic avenues.
- Understanding the impact of combined chemokine expression is crucial.
Conclusions:
- Chemokine modulation represents a promising therapeutic strategy for cardiovascular diseases.
- Future drug development must consider the complex interplay of multiple chemokines.
- Careful scrutiny of therapeutic strategies is essential for effective CVD treatment.
Abstract:
Cardiovascular diseases, including atherosclerosis and the dreaded complication myocardial infarction, represent the major cause of death in western countries. It is now generally accepted that chemokines tightly control and modulate all the events which lead to initiation and progression of cardiovascular diseases, making them very attractive therapeutic targets for the pharmaceutical industry. Various studies showed until now the effects of antagonizing/ neutralizing chemokines or blocking chemokine receptors on cardiovascular pathology. The modulation of the CCL2/CCR2, CCL5/CCR1-CCR5, CXCL12/CXCR4 pathways by preventing receptor--ligand interaction, chemokine-glycosaminoglycan interaction, heteromerization, or interfering with the signaling pathways has proven to have high potential in future drug development. However, while trying to understand the effects of individual chemokines, the biologic consequences of multiple and concomitant chemokine expression on leukocyte migration and function should be taken into account as well. Therefore, many aspects should be considered and carefully scrutinized, when devising therapeutic strategies.
Related Concept Videos
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Atherosclerosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
